Skip to main content

Table 1 Baseline patient and treatment characteristics

From: Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Sex

F

M

M

M

M

F

Tumor entity

Breast (adenocarcinoma)

Prostate (adenocarcinoma)

Rectum (adenocarcinoma)

Rectum (adenocarcinoma)

Primary: lung (small cell neuroendocrine); secondary: liver + bone

(left shoulder)

Rectum (adenocarcinoma)

Tumor stage

IA

IV

IIA

IIIB

IV

IIIA

Age (years)

50

74

54

74

70

40

Height (m)

1.77

1.70

1.82

1.72

1.76

1.65

Baseline weight (kg)

88.9

67.5

76.4

89.4

114.0

55.9

Main reasons for KD

Anticipated fat

mass reduction;

anti-cancer effects

Anticipated body weight preservation

Anticipated anti-cancer effects

Anticipated anti-cancer effects; patient refusal of surgery

Anticipated anti-cancer effects; possibility to take action by oneself

Anticipated anti-cancer effects

  1. The overall tumor staging refers to the AJCC 7th edition